ICU或脓毒血症液体复苏__培训课件.pptVIP

下载本文档

4
0
约5万字
约 56页
2016-12-30 发布于浙江
举报
版权申诉

ICU或脓毒血症液体复苏__培训课件.ppt

1、本文档共56页，可阅读全部内容。
2、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

HES 130/0.4 vs saline (CHEST study): safety and efficacy in the ICU? AKI, acute kidney injury; CHEST, Crystalloid versus Hydroxyethyl Starch Trial; HES, hydroxyethyl starch; ICU, intensive care unit; RIFLE, risk, injury, failure, loss and end-stage kidney injury; RRT, renal replacement therapy Myburgh et al. N Engl J Med 2012; 367: 1901–1911 Aim Evaluate safety of HES 130/0.42* vs saline in ICU patients Study design Multicentre, parallel group, blinded, randomised Comparison 6% HES 130/0.4 (N=3315) 0.9% saline (N=3336) Maximum daily dose: 50 mL/kg body-weight/day However, the mean daily dose was 526 mL, substantially max Patients ≥18 years Required fluid resuscitation in the ICU Heterogenous; patients with sepsis at baseline:HES 130/0.4 (N=979), saline (N=958) Primary endpoint Death at 90 days post-randomisation Secondary endpoints Incidence of AKI (5-category RIFLE criteria) Use of RRT Duration of RRT and mechanical ventilation Specified new organ failures Cause-specific mortality Within 90 days post-randomisation Trend to higher mortality with HES 130/0.4 vs saline in the ICU1 CI, confidence interval; HES, hydroxyethyl starch; RR, relative risk 1. Myburgh et al. N Engl J Med 2012; 367: 1901–1911; 2. Perner et al. N Engl J Med 2012; 367: 124–134 RR 1.06 (95% CI 0.96, 1.18) p=0.26 Rate of death was lower than expected due to patient exclusions, and substantially lower than that observed in similar studies (e.g. 6S study)1,2 However, a non-statistically significant increase in mortality at day 90 was observed with HES 130/0.4 compared with saline1 HES 130/0.4 Saline HES 130/0.4 significantly increases risk of RRT vs saline in the ICU Within 90 days post-randomisation. CI, confidence interval; HES, hydroxyethyl starch; RR, relative risk; RRT, renal replacement therapy Myburgh et al. N Engl J Med 2012; 367: 1901–1911 RR 1.21 (95% CI 1.00, 1.45) 21% p=0.04 Saline HES 130/0.4 Creatinine levels* revealed significantly higher risk of injury and failure in the H